SavedAdd your journal

Journals / Hacettepe Üniversitesi Sağlık Bilimleri Fakültesi Dergisi / 2019 / Cilt: 6 - Sayı: 2

Probiotics and Prebiotics in the Treatment of Irrıtable Bowel Syndrome and Functional Dyspepsia

İrritabl Bağırsak Sendromu ve Fonksiyonel Dispepsi Tedavisinde Probiyotikler ve Prebiyotikler

Gözde AĞCA
Ece YALÇIN
Zeynep GÖKTAŞ
Pages
178–191
Publication Date
2019-08-29
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review evaluates and summarizes the literature on the use of probiotics and prebiotics as a treatment and their efficacy in reducing the symptoms in IBS and FD patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In the intestinal flora, there seems to be about 500 microorganism species and 98% of them are found to be useful.
📊
Key Findings & Data:However intestinal flora can contain different microorganisms in each individual.
💡
Conclusion & Impact:This review evaluates and summarizes the literature on the use of probiotics and prebiotics as a treatment and their efficacy in reducing the symptoms in IBS and FD patients.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:İrritabl barsak sendromu · dispepsi · probiyotik

Abstract

In the intestinal flora, there seems to be about 500 microorganism species and 98% of them are found to be useful. However intestinal flora can contain different microorganisms in each individual. Probiotics and prebiotics might have beneficial effects such as increasing immunity, preventing inflammation by stimulating inflammation-inhibiting cytokines, inhibiting the reproduction of pathogens and the involvement of viruses. Irritable Bowel Syndrome (IBS) and Functional Dyspepsia (FD) are disorders associated with upper gastrointestinal system symptoms in addition to symptoms such as abdominal pain, diarrhea and / or constipation, bloating, early satiety, and nausea. Abdominal pain, gas, bloating and nausea complaints are common and very difficult to treat in IBS and FD patients, and may affect the social life and quality of life of the individual. Probiotics and prebiotics are claimed to be effective in treating these symptoms with positive effects on the health of the individual. This review evaluates and summarizes the literature on the use of probiotics and prebiotics as a treatment and their efficacy in reducing the symptoms in IBS and FD patients.

🔖

Cite This Article

AĞCA, G., YALÇIN, E., GÖKTAŞ, Z. (2019). Probiotics and Prebiotics in the Treatment of Irrıtable Bowel Syndrome and Functional Dyspepsia. Hacettepe Üniversitesi Sağlık Bilimleri Fakültesi Dergisi, Cilt: 6 - Sayı: 2, 178–191. https://ajindex.com/articles/670855

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Agrawal, A., Houghton, L. A., Morris, J., Reilly, B., Guyonnet, D., Goupil Feuillerat, N. ve diğerleri. (2009). Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN‐173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Alimentary pharmacology & therapeutics, 29(1), 104-114.
  2. Al-Sheraji, S. H., Ismail, A., Manap, M. Y., Mustafa, S., Yusof, R. M., & Hassan, F. A. (2013). Prebiotics as functional foods: A review. Journal of Functional Foods, 5(4), 1542-1553.
  3. Aro, P., Talley, N. J., Ronkainen, J., Storskrubb, T., Vieth, M., Johansson, S. E. ve diğerleri. (2009). Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study. Gastroenterology, 137(1), 94-100.
  4. Blaut, M. (2002). Relationship of prebiotics and food to intestinal microflora. European Journal of Nutrition, 41(1), i11-i16. Brun, R., & Kuo, B. (2010). Functional dyspepsia. Therap Adv Gastroenterol, 3(3), 145-164. doi:10.1177/1756283x10362639. Butel, M. J. (2014). Probiotics, gut microbiota and health. Médecine et Maladies Infectieuses, 44(1), 1-8. doi:https://doi.org/10.1016/j.medmal.2013.10.002
  5. Canavan, C., West, J., & Card, T. (2014). The epidemiology of irritable bowel syndrome. Clinical Epidemiology, 6, 71-80. doi:10.2147/CLEP.S40245 Carvalho, R. V. B., Lorena, S. L. S., de Souza Almeida, J. R., & Mesquita, M. A. (2009).
  6. Food Intolerance, Diet Composition, and Eating Patterns in Functional Dyspepsia Patients. Digestive Diseases and Sciences, 55(1), 60. doi:10.1007/s10620-008-0698-8
  7. Chen, S. L. (2013). A review of drug therapy for functional dyspepsia. Journal of digestive diseases, 14(12), 623-625.
  8. Chey, W. D., Kurlander, J., & Eswaran, S. (2015). Irritable bowel syndrome: A clinical review. JAMA, 313(9), 949-958. doi:10.1001/jama.2015.0954 Coşkun, T. (2007).
  9. Pro-, Pre-ve sinbiyotikler. Turkiye Klinikleri Journal of Pediatrical Sciences, 3(6), 82-98.
  10. De Ponti, F., & Tonini, M. (2001). Irritable Bowel Syndrome. Drugs, 61(3), 317-332. doi:10.2165/00003495-200161030-00001
  11. Dibaise, J. K., Islam, R. S., Dueck, A. C., Roarke, M. C., & Crowell, M. D. (2016). Psychological distress in Rome III functional dyspepsia patients presenting for testing of gastric emptying. Neurogastroenterol Motil, 28(2), 196-205. doi:10.1111/nmo.12709 Duncanson, K. R., Talley, N. J., Walker, M. M., & Burrows, T. L. Food and functional dyspepsia: a systematic review. Journal of